The correlation between SMAD4 mutations and clinico-molecular features in a Chinese non-small cell lung cancer (NSCLC) cohort was studied using next-generation sequencing. Integrated bioinformatics analyses based on public databases were conducted to further investigate the prognostic value of SMAD4. Results showed that SMAD4 alteration was associated with poor survival and resistance to platinum-based chemotherapy, suggesting that SMAD4 alteration might be a predictive marker in NSCLC.
- Yue Wang
- Qianqian Xue
- Yuan Li
